Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy
Author(s) -
Yehoda M. Martei,
Mohan Narasimhamurthy,
Dipho I. Setlhako,
Gezahen Negusse Ayane,
Tlotlo Ralefala,
Sebathu Chiyapo,
Robert Gross,
Lawrence N. Shulman,
Surbhi Grover,
Angela DeMichele
Publication year - 2022
Publication title -
jco global oncology
Language(s) - English
Resource type - Journals
ISSN - 2687-8941
DOI - 10.1200/go.22.00016
Subject(s) - medicine , hazard ratio , breast cancer , chemotherapy , zidovudine , odds ratio , gastroenterology , prospective cohort study , oncology , cancer , human immunodeficiency virus (hiv) , confidence interval , immunology , viral disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom